An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

NCT07680166 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Sarcoidosis

Interventions

DRUG: XTMAB-16
DRUG: Placebo

Sponsor

Xentria, Inc.